Status:
COMPLETED
Pediatric Burn Treatment Using Tilapia Skin as a Xenograft for Superficial-Partial Thickness Wounds
Lead Sponsor:
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Conditions:
Burns
Eligibility:
All Genders
2-12 years
Phase:
PHASE2
Brief Summary
This study aims to evaluate the efficacy of Nile tilapia skin as a xenograft for the treatment of partial-thickness burn wounds in children.
Detailed Description
This is an open-label, monocentric, randomized phase II pilot study conducted in Fortaleza, Brazil. The study population consisted of 30 children between the ages of 2 and 12 years with superficial "p...
Eligibility Criteria
Inclusion
- Children between the ages of 2 and 12 years admitted to our institution with superficial partial thickness burns less than 72 hours from the thermal injury
Exclusion
- Patients were excluded for a burn greater than 15% total body surface area (TBSA);
- Presence of a previous treatment for the current burn;
- Presence of a chemical or electrical burn;
- Presence of other significant diseases that could impact the volunteer's participation in the study;
- Presence of hypersensitivity to materials used in the study or to related compounds.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04391582
Start Date
May 1 2017
End Date
April 12 2018
Last Update
May 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Burn Treatment Center, Dr. José Frota Institute
Fortaleza, Ceará, Brazil, 60025-061